Solvonis Therapeutics plc
SVNS.L · LSE
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | – | -£335 | -£626 | -£1,994 |
| Dep. & Amort. | – | £0 | £57 | £83 |
| Deferred Tax | – | £0 | £0 | £0 |
| Stock-Based Comp. | – | £146 | £7 | £369 |
| Change in WC | – | £25 | £73 | -£228 |
| Other Non-Cash | – | £15 | £66 | £1,425 |
| Operating Cash Flow | – | -£149 | -£423 | -£345 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | – | £0 | -£4 | £21 |
| Net Acquisitions | – | £0 | £0 | £0 |
| Inv. Purchases | – | £0 | -£13 | £0 |
| Inv. Sales/Matur. | – | £0 | £0 | £0 |
| Other Inv. Act. | – | -£20 | £0 | -£16 |
| Investing Cash Flow | – | -£20 | -£17 | £5 |
| Financing Activities | – | – | – | – |
| Debt Repay. | – | £0 | £0 | £0 |
| Stock Issued | – | £41 | £112 | £0 |
| Stock Repurch. | – | £0 | £0 | £0 |
| Dividends Paid | – | £0 | £0 | £0 |
| Other Fin. Act. | – | -£41 | £312 | £0 |
| Financing Cash Flow | – | £0 | £312 | £0 |
| Forex Effect | – | -£14 | £0 | -£27 |
| Net Chg. in Cash | – | -£183 | £27 | -£367 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | – | £940 | £155 | £522 |
| End Cash | – | £757 | £27 | £155 |
| Free Cash Flow | – | -£149 | -£427 | -£324 |